A recent animal trial exploring the relationship between zinc supplementation and hyperglycemia and associated metabolic abnormalities revealed that following zinc supplementation, diabetic rats had a significant increase in plasma albumin, decrease in plasma urea and creatinine levels, and significant changes in insulin sensitivity indices HOMA-IR, HOMA-B, and QUICKI. The gene discussed is ALB; the disease is Hyperglycemia.